Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Aug 07, 2020 4:04pm

94 Views

Post# 31380896

todays trades

House Positions for C:VXL from 20200807 to 20200807

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	161,000	15,945	0.099	126,000	12,595	0.10	35,000	-3,350
53 Morgan Stanley	19,000	1,900	0.10	0			19,000	-1,900
39 Merrill Lynch	18,800	1,880	0.10	0			18,800	-1,880
33 Canaccord	14,000	1,330	0.095	100	10	0.10	13,900	-1,320
143 Pershing	8,000	800	0.10	0			8,000	-800
9 BMO Nesbitt	3,000	300	0.10	0			3,000	-300
124 Questrade	2,850	285	0.10	0			2,850	-285
14 ITG	1,300	130	0.10	0			1,300	-130
85 Scotia	1,200	115	0.096	0			1,200	-115
68 Leede	0			880	88	0.10	-880	88
7 TD Sec	25,060	2,502	0.10	37,025	3,702	0.10	-11,965	1,200
79 CIBC	7,275	727	0.10	24,130	2,292	0.095	-16,855	1,565
2 RBC	28,750	2,777	0.097	102,100	10,005	0.098	-73,350	7,228
TOTAL	290,235	28,691	0.099	290,235	28,692	0.099	0	1